Bredt David
CIK 0002022087
Chief Scientific Officer
Filings
16
Latest Feb 19, 2026
Issuers covered
1
Showing
16 of 16
Page 1
Track record
21 of 21 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 21 | 43% | -8.8% | -3.9% | +12.3% | -68.2% |
| 90 days | 21 | 10% | -31.6% | -21.1% | +6.7% | -120.8% |
| 180 days | 13 | 0% | -80.6% | -87.8% | -11.7% | -172.8% |
| 365 days | 3 | 0% | -241.7% | -280.0% | -162.8% | -282.4% |
Issuers
Companies where Bredt David has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | 16 | Feb 19, 2026 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|